The resurgence of ‘ticking timebomb’ tuberculosis

resisttb
Jun 27, 2023
1 min read

The Week highlights that TB has reclaimed its position as the most deadly infectious disease. The resurgence of the disease has been attributed primarily to the impact of the Covid-19 pandemic. Read more here.

Recent Posts

See All

Phase II data suggest new drug could unlock shorter TB treatment

New data from a phase II trial showed that sorfequiline showed greater activity against drug-susceptible TB compared to existing treatments at 8 weeks in addition to a more favorable safety profile. T

The WHO Global Tuberculosis Report 2025: 1.3 Drug-Resistant TB

MDR/RR-TB has been decreasing globally since 2015, with the estimated number of people who have developed MDR-TB in 2024 at 390,000. Regionally, the number of people who developed MDR-TB (incident cas

Life-saving DR-TB treatments even more affordable following newest bedaquiline price decrease

The lowest cost of the full BPaLM regimen, which is the most recommended treatment for drug resistant tuberculosis (DR-TB), has now...

Comments